Marjeta Tercelj

Summary

Affiliation: University Medical Centre
Country: Slovenia

Publications

  1. ncbi In vitro and in vivo reactivity to fungal cell wall agents in sarcoidosis
    M Tercelj
    Department for Respiratory and Allergic Diseases, the University Medical Centre Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia Biofact Environmental Health Research Center, Lerum, Sweden
    Clin Exp Immunol 166:87-93. 2011
  2. ncbi DNA-based sputum cell image analysis for lung cancer in a clinical setting
    Marjeta Tercelj
    Department of Respiratory Diseases, Ljubljana University Medical Center, Slovenia
    Acta Cytol 52:584-90. 2008
  3. ncbi Microbial antigen treatment in sarcoidosis--a new paradigm?
    Marjeta Tercelj
    Unit of Respiratory Diseases and Allergy, University Medical Center, Ljubljana, Slovenia
    Med Hypotheses 70:831-4. 2008
  4. ncbi Fungal exposure in homes of patients with sarcoidosis - an environmental exposure study
    Marjeta Tercelj
    Clinic of Respiratory Diseases and Allergy, University Medical Centre, Ljubljana, Slovenia
    Environ Health 10:8. 2011
  5. ncbi Antifungal treatment in sarcoidosis--a pilot intervention trial
    Marjeta Tercelj
    Unit of Respiratory Diseases and Allergy, University Medical Center, Clinical Center, Zaloska 7, 1525 Ljubljana, Slovenia
    Respir Med 101:774-8. 2007
  6. ncbi A hospital outbreak of Legionella from a contaminated water supply
    Marjeta Tercelj-Zorman
    Division of Internal Medicine, University Medical Center, Ljubljana, Slovenia
    Arch Environ Health 59:156-9. 2004
  7. ncbi Antifungal medication is efficient in the treatment of sarcoidosis
    Marjeta Tercelj
    Clinic of Pulmonary Disease and Allergy, University Medical Centre, Zaloska 7, 1000 Ljubljana, Slovenia
    Ther Adv Respir Dis 5:157-62. 2011
  8. ncbi Chitotriosidase activity in sarcoidosis and some other pulmonary diseases
    Marjeta Tercelj
    Department of Respiratory Diseases and Allergy, University Medical Centre, Ljubljana, Slovenia
    Scand J Clin Lab Invest 69:575-8. 2009
  9. ncbi Fungal cell wall agents suppress the innate inflammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitro
    Sanja Stopinšek
    Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloska 4, 1000 Ljubljana, Slovenia
    Int Immunopharmacol 11:939-47. 2011
  10. ncbi Fire-eater's lung complicated by an infectious abscess requiring surgical treatment
    Matevz Harlander
    Department of Pulmonary Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia
    Respirology 15:379-81. 2010

Collaborators

Detail Information

Publications15

  1. ncbi In vitro and in vivo reactivity to fungal cell wall agents in sarcoidosis
    M Tercelj
    Department for Respiratory and Allergic Diseases, the University Medical Centre Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia Biofact Environmental Health Research Center, Lerum, Sweden
    Clin Exp Immunol 166:87-93. 2011
    ..The influence of FCWA on inflammatory cells and their interference with the inflammatory defense mechanisms in terms of cytokine secretion could be important factors for the development of sarcoidosis...
  2. ncbi DNA-based sputum cell image analysis for lung cancer in a clinical setting
    Marjeta Tercelj
    Department of Respiratory Diseases, Ljubljana University Medical Center, Slovenia
    Acta Cytol 52:584-90. 2008
    ..To measure cell nuclei characteristics, previously reported to express probability for lung cancer, in subjects with different forms ofpulmonary disease and those without disease...
  3. ncbi Microbial antigen treatment in sarcoidosis--a new paradigm?
    Marjeta Tercelj
    Unit of Respiratory Diseases and Allergy, University Medical Center, Ljubljana, Slovenia
    Med Hypotheses 70:831-4. 2008
    ..It is suggested that diagnostic tools for the presence of microbes are used in patients with sarcoidosis and that antimicrobial treatment is considered in cases resistant to corticosteroids...
  4. ncbi Fungal exposure in homes of patients with sarcoidosis - an environmental exposure study
    Marjeta Tercelj
    Clinic of Respiratory Diseases and Allergy, University Medical Centre, Ljubljana, Slovenia
    Environ Health 10:8. 2011
    ..To assess the influence of the environmental exposure, a study was undertaken to determine the exposure to fungi in homes of subjects with sarcoidosis...
  5. ncbi Antifungal treatment in sarcoidosis--a pilot intervention trial
    Marjeta Tercelj
    Unit of Respiratory Diseases and Allergy, University Medical Center, Clinical Center, Zaloska 7, 1525 Ljubljana, Slovenia
    Respir Med 101:774-8. 2007
    ..Sarcoidosis is generally treated with corticosteroids that are not always an effective therapy...
  6. ncbi A hospital outbreak of Legionella from a contaminated water supply
    Marjeta Tercelj-Zorman
    Division of Internal Medicine, University Medical Center, Ljubljana, Slovenia
    Arch Environ Health 59:156-9. 2004
    ..The healthy personnel and patients closest to the source acquired legionellosis, suggesting that risk was related less to compromised patients than to exposure...
  7. ncbi Antifungal medication is efficient in the treatment of sarcoidosis
    Marjeta Tercelj
    Clinic of Pulmonary Disease and Allergy, University Medical Centre, Zaloska 7, 1000 Ljubljana, Slovenia
    Ther Adv Respir Dis 5:157-62. 2011
    ..The present study was performed to compare the effects of antifungal treatment with corticosteroid treatment in sarcoidosis...
  8. ncbi Chitotriosidase activity in sarcoidosis and some other pulmonary diseases
    Marjeta Tercelj
    Department of Respiratory Diseases and Allergy, University Medical Centre, Ljubljana, Slovenia
    Scand J Clin Lab Invest 69:575-8. 2009
    ..Particularly high levels have been reported for chitotriosidase. In this study, we evaluate whether determining chitotriosidase in serum would be useful in the diagnosis and clinical management of patients with sarcoidosis...
  9. ncbi Fungal cell wall agents suppress the innate inflammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitro
    Sanja Stopinšek
    Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloska 4, 1000 Ljubljana, Slovenia
    Int Immunopharmacol 11:939-47. 2011
    ..In conclusion, a long-term and massive exposure to LPS and FCWA (e.g., organic dust) may cause an important disruption of normal immune response and allow development and/or persistence of various immunopathological events...
  10. ncbi Fire-eater's lung complicated by an infectious abscess requiring surgical treatment
    Matevz Harlander
    Department of Pulmonary Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia
    Respirology 15:379-81. 2010
    ..We describe a case of fire-eater's pneumonia that was complicated by an infectious lung abscess with substantial haemoptysis. Conservative treatment was inadequate. Surgical resection was necessary and proved to be successful...
  11. ncbi Association of angiotensin-converting enzyme/DD genotype with sarcoidosis susceptibility in Slovenian patients
    Barbara Salobir
    Department of Pulmonary Diseases and Allergy, University Medical Center, Ljubljana, Slovenia
    Med Sci Monit 13:CR538-42. 2007
    ..The purpose of this study was to evaluate the possible association of angiotensin-converting enzyme (ACE) gene insertion (I)/deletion (D) polymorphism with sarcoidosis in the Slovene population...
  12. ncbi Acquisition of fluorescence and reflectance spectra during routine bronchoscopy examinations using the ClearVu Elite device: pilot study
    Marjeta Tercelj
    Department for Respiratory Diseases, University Medical Hospital, Ljubljana, Slovenia
    Lung Cancer 50:35-42. 2005
    ....
  13. ncbi CD69 expression on CD4+ T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigens
    Bojana Avgustin
    Institute of Microbiology and Immunology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
    Clin Diagn Lab Immunol 12:101-6. 2005
    ..537; P<0.001). Our results demonstrate the usefulness of the determination of CD69 on CD4 T lymphocytes after in vitro stimulation with tuberculin as a rapid indicator of immune sensitization against Mycobacterium tuberculosis...
  14. ncbi Polymorphisms in genes coding for mediators in the interleukin cascade and their effect on susceptibility to sarcoidosis in the Slovenian population
    Ales Maver
    Division of Medical Genetics, Department of Gynecology and Obstetrics, University Clinical Centre, Ljubljana 1000, Slovenia
    Int J Mol Med 20:385-90. 2007
    ..In conclusion, we demonstrated that the -174G>C promotor polymorphism in the IL-6 gene may be a risk factor for sarcoidosis...
  15. ncbi In vivo assessment and evaluation of lung tissue morphologic and physiological changes from non-contact endoscopic reflectance spectroscopy for improving lung cancer detection
    Yasser S Fawzy
    Perceptronix Medical Inc, Suite 400, 555 West 8th Avenue, Vancouver, British Columbia V5Z 1C6, Canada
    J Biomed Opt 11:044003. 2006
    ..The results also showed that the malignant lung lesions can be differentiated from normal tissue/benign lesions with both diagnostic sensitivity and specificity of better than 80%...